oldid78823

Fewer new Ozone products than expected

Dan Schiopu runs the domestic operations of the British pharmaceutical group Ozone. He says that given the market conditions, Ozone Laboratories has added another 30 products to its portfolio, below the company''s initial target. "Consumption growth below the...